patrick retweetledi
patrick
807 posts

patrick retweetledi

McTominay. Shanks. KT. The Mayor.
Proof that last night did happen ⤵️
#FIFAWorldCup | @FIFAWorldCup
English
patrick retweetledi

New article from @Austin_Health senior #IBD pharmacist Patrick Hilley: Implementation of values-based healthcare in inflammatory bowel disease—a review. academic.oup.com/ecco-jcc/advan…
English
patrick retweetledi

📌Biologic safety in #IBD post liver transplant - what’s safest?
💊Gut-specific (VDZ) v systemic (aTNF, UST) agents = similar infectious events
⚠️ Steroid co-therapy = ⬆️ severe infections
Out in AP&T
🔗doi.org/10.1111/apt.70…
👏Congrats #SimoneChin!
#GITwitter #livertwitter

English
patrick retweetledi

Pharmacist integration into inflammatory bowel disease multidisciplinary teams - what are their roles, & what value do they add? A literature review from our IBD pharmacist @philley89 and MD co-authors. academic.oup.com/ibdjournal/art…
English
patrick retweetledi

PREDICT UC trial optimizing infliximab dose in patients with #ASUC
Initially no differences at day 8 BUT
✅intensified better if albumin<25
✅ intensified better if crp>50
Presented by Matthew Chuen Seng Choy at @DDWMeeting #DDW2024




English
patrick retweetledi

Just published, co-authored by IBD pharmacist Patrick Hilley: Safety & effectiveness of Janus kinase (JAK) inhibitors in the management of inflammatory bowel disease following liver transplantation. academic.oup.com/ecco-jcc/artic…
English

Ustekinumab PK data in POWER study #UEGW2023
No serum drug exposure - response relationship.
1. Is there any role for higher doses of UST in Crohn's pts who have loss of response either by:
- dose escalation (to q4w)
- re-induction
2. TDM for UST is unlikely to be useful.




English
patrick retweetledi

The 2024 MacHSR Future Leaders Fellowship is open to established clinicians looking to do health services research. You'll gain:
• Formal HSR training
• Protected research time
• Expert supervision
• Networking opportunities
Learn more & apply today: ow.ly/AK9A50QCtoE

English

Enjoyed chatting rugby and what’s going on in the game with @Nigel_Farage on @GBNEWS tonight! #TalkingPints
English
patrick retweetledi

Switching patients with IBD from intravenous to subcutaneous biologics might improve convenience for patients but results in a financial loss to health services, an Australian study suggests. thelimbic.com/gastroenterolo…
English

Opportunity cost of improving access to healthcare via switch to subcutaneous infliximab and vedolizumab.
onlinelibrary.wiley.com/share/author/T…
English

Dear friends. We are very excited to announce our UK and Ireland headline tour in Feb/March '24.
Tix are on general sale this Fri at 10am UK time. Sign up to our mailing list for pre-sale access this Wed.
linktr.ee/86tvsband
Get on it early!!
Love,
86TVs

English
patrick retweetledi

Outcomes out to 12 months after sequential use of high‐dose tofacitinib following infliximab in acute severe ulcerative colitis - Eqbal - 2023 - Internal Medicine Journal - Wiley Online Library onlinelibrary.wiley.com/doi/10.1111/im…
@philley89 @DrMattChoy
English

@IBDcanruti @hgermanstrias @CIBERehd @GTRecerca Indeed. What I find esp. appalling is that after >20y of infliximab, we still dont have a single proper RCT to know if intensified dosing is beneficial in our most dire pts hospitalized with acute severe colitis or having severe perianal dis. Only circumstantial data.
English

Two decades using it, doubts already persist...
@hgermanstrias @CIBERehd
@GTRecerca pubmed.ncbi.nlm.nih.gov/37562771/
Tiana, España 🇪🇸 English
patrick retweetledi

We want to improve patient experience of abortion care in Melbourne’s north.
redcap.link/codesigningabo…
@kate_chaouki @LisaHui4 @cmvaug @BodilRasmussen4

English



